Rocket Lab (RKLB) Q1 2026 earnings review
Explosive Top-Line Growth, But Profitability Reverses Course
Rocket Lab continues its aggressive acceleration. Q1 2026 delivered record revenue of $200.3M (+63.5% YoY), surpassing all internal guidance. The launch business is operating at a blistering pace, securing more contracts in Q1 (31 Electron/HASTE, 5 Neutron) than in the entirety of 2025. However, while top-line execution and the new $2.2B backlog are stellar, profitability is hitting a speed bump. After quarters of steady margin expansion, Q2 guidance indicates a sudden reversing trend: Adjusted EBITDA losses will widen to a midpoint of $23M, and gross margins are set to compress by roughly 400 basis points sequentially.
🐂 Bull Case
Selection for the Department of War's Space Based Interceptor (SBI) program under Golden Dome validates Rocket Lab's pivot from a launch provider to a vertically-integrated national security prime.
Selling more launches in Q1 2026 than in all of 2025 provides massive revenue visibility and proves the market is hungry for reliable small and medium-lift capability.
🐻 Bear Case
Q2 guidance projects gross margins dropping back to 34% (GAAP) and 39% (Non-GAAP), breaking a multi-quarter streak of margin expansion and signaling potential mix headwinds.
Basic weighted average shares outstanding ballooned 20% YoY from 505.6M to 605.4M. Aggressive ATM offerings are funding growth, but heavily diluting existing shareholders.
⚖️ Verdict: ⚪
Neutral/Bullish. The operational execution and backlog growth are undeniably impressive. However, the Q2 margin compression and steady shareholder dilution cap immediate enthusiasm until Neutron begins generating revenue.
Key Themes
Unprecedented Launch Demand
Launch bookings are accelerating at an extraordinary pace. Rocket Lab signed 31 new Electron and HASTE contracts, plus 5 dedicated Neutron launches in Q1 alone. Eclipsing the total sales of FY25 in a single quarter proves that commercial and government customers view Rocket Lab as the definitive alternative to SpaceX.
Aggressive Vertical Integration via M&A
Management continues to buy its way up the value chain. The Mynaric acquisition establishes a European footprint and optical comms capability, while the new definitive agreement to acquire Motiv Space Systems brings precision mechanisms and solar array drive assemblies (SADAs) in-house. This insources supply-constrained components and protects margins on large satellite builds.
Golden Dome & National Security Tailwinds
The macro defense environment is a massive catalyst. Rocket Lab's selection to support the Space Based Interceptor (SBI) program under the Golden Dome initiative directly links the company to what could become the U.S. government's most lucrative national security space program. This elevates Rocket Lab from a component supplier to a strategic prime.
Profitability Trajectory is Reversing
Despite a 16% sequential revenue jump guided for Q2, margins are reversing. GAAP Gross Margin is guided to 34% (down from 38.2% in Q1), and Non-GAAP Gross Margin to 39% (down from 43.0%). Correspondingly, Adjusted EBITDA losses are guided to widen from $11.8M to a midpoint of $23.0M. This suggests that low-margin Space Systems contracts or heavy Neutron prep costs are diluting overall profitability.
Continuous Shareholder Dilution
Growth is expensive, and shareholders are footing the bill. Basic weighted average shares outstanding rose from 505.6M in Q1 2025 to 605.4M in Q1 2026. The company utilized its ATM offering to raise $450.3M in Q1 alone, padding cash reserves but heavily diluting existing equity.
Neutron Spending CapEx and OpEx Burden
R&D spending continues to accelerate to support the Neutron vehicle launch later this year. GAAP R&D jumped to $80.5M in Q1 (up 46% YoY). Until Neutron has its inaugural flight and begins fulfilling its 5-launch backlog, it will remain a significant drag on cash flow.
Other KPIs
Rocket Lab ended the quarter with $1.2B in cash and cash equivalents and $177.9M in current marketable securities, largely driven by $450.3M in ATM offering proceeds. This war chest deeply de-risks Neutron's final development phase and provides dry powder for further M&A.
Stable YoY (vs -$54.2M in 25Q1). While revenue grew by 63.5%, the cash burn from operations remained flat. This reflects massive working capital investments, specifically a $35.6M increase in Accounts Receivable and a $24.5M increase in Inventories to support the massive $2.2B backlog.
Guidance
Accelerating. The midpoint of $232.5M implies a 61% YoY growth rate and a robust 16% sequential increase, proving that the company's execution on backlog conversion is scaling properly.
Reversing. Down sequentially from 38.2% in Q1. Management needs to clarify if this is driven by lower-margin Space Systems mix, initial Neutron tooling amortization, or pricing pressures.
Reversing. After narrowing to an $11.8M loss in Q1, the loss is expected to widen significantly. This highlights that operating leverage is temporarily pausing as the company scales headcount and capabilities ahead of the Neutron debut.
Key Questions
Drivers of Q2 Margin Compression
With sequential revenue guided up 16%, why is gross margin guiding down 400 basis points? Is this purely a mix shift toward early-stage, lower-margin Space Systems contracts like the SDA and SBI programs, or are there launch margin headwinds?
ATM Utilization and M&A Pipeline
You tapped $450M from the ATM in Q1 to push liquidity over $2 billion. With Mynaric and Motiv already announced, is this war chest earmarked for larger 'needle-moving' acquisitions, or simply a buffer for Neutron's ramp?
Neutron Archimedes Status
You noted 'continued progress' on Archimedes engine qualification. Given the timeline to debut Neutron 'later this year,' what specific hot-fire milestones remain before the engines can be integrated onto the first flight vehicle?